Publicacions
-
Coll T, Rodrïguez-Calvo R, Barroso E, Serrano L, Eyre E, Palomer FX and Vazquez M.
Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.
Current Molecular Pharmacology . 2(1): 46-55.
-
Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer FX, Laguna JC, Michalik L, Wahli W and Vazquez M.
Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Diabetes . 57(8): 2149-2157. Nº de cites: 103
-
Coll T, Eyre E, Rodríguez-Calvo R, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.
Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells.
JOURNAL OF BIOLOGICAL CHEMISTRY . 283(17): 11107-11116. Nº de cites: 284
-
Planavila A, Rodríguez-Calvo R, Palomer FX, Coll T, Sánchez RM, Merlos M, Laguna JC and Vazquez M.
Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1781(1-2): 26-35. Nº de cites: 15
-
Rodríguez-Calvo R, Serrano L, Barroso E, Coll T, Palomer FX, Camins A, Sánchez RM, Alegret M, Merlos M, Pallàs M, Laguna JC and Vazquez M.
Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 62(12): 1326-1336. Nº de cites: 22
-
Coll T, Jové M, Rodríguez-Calvo R, Eyre E, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.
Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.
Diabetes . 55(10): 2779-2787. Nº de cites: 125